Efficacy of dipalmitoylphosphatidylcholine liposome against African trypanosomes

Journal of Parasitology

Volumn 92, Issue 2, 2006, Pages 389-393

  Kuboki, Noritaka ^a   Yokoyama, Naoaki ^a   Kojima, Naoya ^a,b   Sakurai, Tatsuya ^a   Inoue, Noboru ^a   Sugimoto, Chihiro ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOFURAN DERIVATIVE; DIPALMITOYLPHOSPHATIDYLCHOLINE; LIPOSOME;

HEMOPARASITE; HOST-PARASITE INTERACTION; PARASITE; PARASITE INFESTATION; PROTOZOAN; VERTEBRATE;

AFRICAN TRYPANOSOMIASIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFECT; FEMALE; LIFE CYCLE; MOUSE; NONHUMAN; PARASITEMIA; TRYPANOSOMA; TRYPANOSOMA BRUCEI; TRYPANOSOMA CONGOLENSE; TRYPANOSOMA RHODESIENSE;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANIMALS; FEMALE; LIPOSOMES; MICE; MICE, INBRED BALB C; MOVEMENT; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMA CONGOLENSE; TRYPANOSOMIASIS, AFRICAN;

AFRICA;

ANIMALIA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA BRUCEI; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMA CONGOLENSE; VERTEBRATA;

EID: 33646485584     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-667R.1     Document Type: Article

References (29)

1. BOULANGER, N., R. J. MUNKS, J. V. HAMILTON, F. VOVELLE, R. BRUN, M. J. LEHANE, AND P. BULET. 2002. Epithelial innate immunity: A novel antimicrobial peptide with antiparasitic activity in the blood-sucking insect Stomoxys calcitrans. The Journal of Biological Chemistry 277: 49921-49926.
2. BURCHMORE, R. J., P. O. OGBUNUDE, B. ENANGA, AND M. P. BARRETT. 2002. Chemotherapy of human African trypanosomiasis. Current Concepts in Hospital Pharmacy Management 8: 256-267.
3. CLAYTON, C. E., AND P. MICHELS. 1996. Metabolic compartmentation in African trypanosomes. Parasitology Today 12: 465-471.
4. COOPER, M. G., AND R. E. HAUSMAN. 2003. The cells: A molecular approach, 3rd ed. The American Society for Microbiology, Washington, D.C., 673 p.
5. DAVITZ, M. A., A. M. GURNETT, M. G. LOW, M. J. TURNER, AND V. NUSSENZWEIG. 1987. Decay accelerating factor (DAF) shares a common carbohydrate determinant with the variant surface glycoprotein (VSG) of the African Trypanosoma brucei. Journal of Immunology 138: 520-523.
6. + cytotoxic T lymphocytes. Federation of European Biochemical Societies (FEBS) Letters 441: 353-356.
7. HAJDUK, S., B. ADLER, K. BERTRAND, K. FEARON, K. HAGER, K. HANCOCK, M. HARRIS, A. LE BLANC, R. MOORE, V. POLLARD ET AL. 1992. Molecular biology of African trypanosomes: development of new strategies to combat an old disease. American Journal of the Medical Sciences 303: 258-270.
8. HARDER, A., G. GREIF, AND A. HABERKORN. 2001. Chemotherapeutic approaches to protozoa: kinetoplastida-current level of knowledge and outlook. Parasitology Research 87: 778-780.
9. HIRUMI, H., AND K. HIRUMI. 1989. Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers. Journal of Parasitology 75: 985-989.
10. -, AND -. 1991. In vitro cultivation of Trypanosoma congolense bloodstream forms in the absence of feeder cell layer. Parasitology 102: 225-236.
11. INOUE, N., A. LLUZ, T. MORI, H. NAGASAWA, K. FUJISAK, AND T. MIKAMI. 2000. Novel species specific antigens of Trypanosoma congolense and their different localization among life-cycle stages. Journal of Veterinary Medical Science 62: 1041-1405.
12. JONES, M. N., S. E. FRANCIS, F. J. HUTCHINSON, P. S. HANDLEY, AND I. G. LYLE. 1993. Targeting and delivery of bactericide to adsorbed oral bacteria by use of proteoliposomes. Biochimica et Biophysica Acta 1147: 251-261.
13. -, T. H. SONG, M. KASZUBA, AND M. D. REBOIRAS. 1997. The interaction of phospholipids liposomes with bacteria and their use in the delivery of bactericides. Journal of Drug Targeting 5: 25-34.
14. LANHAM, S. M., AND D. G. GODFREY. 1970. Isolation of salivarian trypanosomes from man and other mammals with DEAE-cellulose. Experimental Parasitology 28: 521-534.
15. MAMANI-MATSUDA, M., J. RAMBERT, D. MALVY, H. LEJOLY-BOISSEAU, S. DAULOUEDE, D. THIOLAT, S. COVES, P. COURTOIS, P. VINCENDEAU, AND M. D. MOSSALAYI. 2004. Quercetin induces apoptosis of Trypanosoma brucei gambiense and decreases the proinflammatory response of human macrophages. Antimicrobial Agents and Chemotherapy 48: 924-929.
16. MATOVU, E., T. SEEBECK, J. C. K. ENYARU, AND R. KAMINSKY. 2001. Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and Nagana in cattle. Microbes and Infection 3: 763-770.
17. MCGWIRE, B. S., C. L. OLSON, B. F. TACK, AND D. M. ENGMAN. 2003. Killing of African trypanosomes by antimicrobial peptides. Journal of Infectious Diseases 188: 146-152.
18. NKEMGU, N. J., R. GRANDE, B. HANSELL, J. H. MCKERROW, C. R. CAFFREY, AND D. STEVERDING. 2003. Improved trypanocidal activities of cathepsin L inhibitors. International Journal of Antimicrobial Agents 2: 155-159.
19. PELLEQUER, Y., M. OLLIVON, AND G. BARRATT. 2004. Formulation of liposomes associated with recombinant interleukin-2: effect on interleukin-2 activity. Biomedicine & Pharmacotherapy 58: 162-167.
20. RODITI, I., H. SCHWARZ, T. W. PEARSON, R. P. BEECROFT, M. K. LIU, J. P. RICHARDSON, H.-J. BUHRING, J. PLEISS, R. BULOW, R. O. WILLIAMS, AND P. OVERATH. 1989. Procyclin gene expression and loss of the variant surface glycoprotein during differentiation of Trypanosoma brucei. The Journal of Cell Biology 108: 737-746.
21. SAPRA, P., AND T. M. ALLEN. 2003. Ligand-targeted liposomal anticancer drugs. Progress in Lipid Research 42: 439-462.
22. 2. Experimental Parasitology 91: 327-333.
23. SHIMIZU, Y., M. NAKATA, J. MATSUNUMA, AND T. MIZUOCHI. 2001. Simultaneous quantification of components of neoglycolipid-coated liposomes using high-performance liquid chromatography with evaporative light scattering detection. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life 754: 127-133.
24. SUGIMOTO, M., K. OHISHI, M. FUKASAWA, K. SHIKATA, H. KAWAI, H. ITAKURA, M. HATANAKA, R. SAKAKIBARA, M. ISHIGURO, M. NAKATA, AND T. MIZOUCHI. 1995. Oligomannose-coated liposomes as an adjuvant for the induction of cell-mediated immunity. Federation of European Biochemical Societies (FEBS) Letters 363: 53-56.
25. TREUMANN, A., N. ZITZMANN, A. HULSMEIER, A. R. PRESCOTT, A. ALMOND, J. SHEEHAN, AND M. A. FERGUSON. 1997. Structural characterisation of two forms of procyclic acidic repetitive protein expressed by procyclic forms of Trypanosoma brucei. The Journal of Molecular Biology 269: 529-547.
26. TROEBERG, L., R. E. MORTY, R. N. PIKE, J. D. LONSDALE-ECCLES, J. T. PALMER, J. H. MCKERROW, AND T. H. COETZER. 1999. Cysteine proteinase inhibitors kill cultured bloodstream forms of Trypanosoma brucei. Experimental Parasitology 91: 349-355.
27. WILLSON, M., N. LAUTH, J. PERIE, M. CALLENS, AND F. R. OPPERDOES. 1994. Inhibition of glyceraldehyde-3-phosphate dehydrogenase by phosphorylated epoxides and α-enones. Biochemistry 33: 214-220.
28. -, Y. H. SANEJOUAND, J. PERIE, V. HANNAERT, AND F. OPPERDOES. 2002. Sequencing, modeling, and selective inhibition of Trypanosoma brucei hexokinase. Chemistry & Biology 9: 839-847.
29. [WHO] WORLD HEALTH ORGANIZATION. 2001. African trypanosomiasis or sleeping sickness. World Health Organization Fact Sheet 2001: 259 (http://www.who.int/mediacentre/factsheets/fs259/en/).